cd40 quantikine kit Search Results


cd40lg  (R&D Systems)
94
R&D Systems cd40lg
Cd40lg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd40lg/product/R&D Systems
Average 94 stars, based on 1 article reviews
cd40lg - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
human cd40l elisa kit  (R&D Systems)
93
R&D Systems human cd40l elisa kit
Human Cd40l Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cd40l elisa kit/product/R&D Systems
Average 93 stars, based on 1 article reviews
human cd40l elisa kit - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
differentiation 40  (R&D Systems)
90
R&D Systems differentiation 40
Differentiation 40, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/differentiation 40/product/R&D Systems
Average 90 stars, based on 1 article reviews
differentiation 40 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
scd40 levels  (R&D Systems)
92
R&D Systems scd40 levels
CD40 gene expression and <t>sCD40</t> levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) polymorphisms. (a) CD40 gene expression in CS and SLE patients, (b) sCD40 levels in CS and SLE patients, (c) and (d) sCD40 levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) genotypes; (e) CD40 gene expression according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients, and (f) sCD40 levels according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients. The qualitative gene expression analysis was obtained through to Pfaffl's method. Mann‐Whitney U test, Kruskal‐Wallis test, and Dunn's post hoc test were used. Fc was obtained through the 2 ‐ΔΔCq method. Data are shown in median and IQR. CS: Control subjects, Fc: Fold change, IQR: Interquartile range, SLE: Systemic Lupus Erythematosus
Scd40 Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd40 levels/product/R&D Systems
Average 92 stars, based on 1 article reviews
scd40 levels - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
human cd40l  (R&D Systems)
93
R&D Systems human cd40l
CD40 gene expression and <t>sCD40</t> levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) polymorphisms. (a) CD40 gene expression in CS and SLE patients, (b) sCD40 levels in CS and SLE patients, (c) and (d) sCD40 levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) genotypes; (e) CD40 gene expression according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients, and (f) sCD40 levels according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients. The qualitative gene expression analysis was obtained through to Pfaffl's method. Mann‐Whitney U test, Kruskal‐Wallis test, and Dunn's post hoc test were used. Fc was obtained through the 2 ‐ΔΔCq method. Data are shown in median and IQR. CS: Control subjects, Fc: Fold change, IQR: Interquartile range, SLE: Systemic Lupus Erythematosus
Human Cd40l, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cd40l/product/R&D Systems
Average 93 stars, based on 1 article reviews
human cd40l - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
mc cd40 expression  (R&D Systems)
86
R&D Systems mc cd40 expression
CD40 gene expression and <t>sCD40</t> levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) polymorphisms. (a) CD40 gene expression in CS and SLE patients, (b) sCD40 levels in CS and SLE patients, (c) and (d) sCD40 levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) genotypes; (e) CD40 gene expression according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients, and (f) sCD40 levels according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients. The qualitative gene expression analysis was obtained through to Pfaffl's method. Mann‐Whitney U test, Kruskal‐Wallis test, and Dunn's post hoc test were used. Fc was obtained through the 2 ‐ΔΔCq method. Data are shown in median and IQR. CS: Control subjects, Fc: Fold change, IQR: Interquartile range, SLE: Systemic Lupus Erythematosus
Mc Cd40 Expression, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mc cd40 expression/product/R&D Systems
Average 86 stars, based on 1 article reviews
mc cd40 expression - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier

Image Search Results


CD40 gene expression and sCD40 levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) polymorphisms. (a) CD40 gene expression in CS and SLE patients, (b) sCD40 levels in CS and SLE patients, (c) and (d) sCD40 levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) genotypes; (e) CD40 gene expression according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients, and (f) sCD40 levels according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients. The qualitative gene expression analysis was obtained through to Pfaffl's method. Mann‐Whitney U test, Kruskal‐Wallis test, and Dunn's post hoc test were used. Fc was obtained through the 2 ‐ΔΔCq method. Data are shown in median and IQR. CS: Control subjects, Fc: Fold change, IQR: Interquartile range, SLE: Systemic Lupus Erythematosus

Journal: Molecular Genetics & Genomic Medicine

Article Title: Association of soluble CD40 levels with ‐1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus

doi: 10.1002/mgg3.1014

Figure Lengend Snippet: CD40 gene expression and sCD40 levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) polymorphisms. (a) CD40 gene expression in CS and SLE patients, (b) sCD40 levels in CS and SLE patients, (c) and (d) sCD40 levels according to −1 C > T (rs1883832) and 6,048 G > T (rs4810485) genotypes; (e) CD40 gene expression according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients, and (f) sCD40 levels according to dominant model of −1 C > T (rs1883832) polymorphism in SLE patients. The qualitative gene expression analysis was obtained through to Pfaffl's method. Mann‐Whitney U test, Kruskal‐Wallis test, and Dunn's post hoc test were used. Fc was obtained through the 2 ‐ΔΔCq method. Data are shown in median and IQR. CS: Control subjects, Fc: Fold change, IQR: Interquartile range, SLE: Systemic Lupus Erythematosus

Article Snippet: The sCD40 levels were determined using a commercial ELISA test (DCCD40 Quantikine ELISA kit [R&D Systems ® ]) according to manufacturer's conditions.

Techniques: Expressing, MANN-WHITNEY

CD40 gene expression and sCD40 levels according to SLE activity. (a) CD40 gene expression according to disease activity (b) sCD40 levels according to disease activity, (c) sCD40 levels and SLICC damage index correlation, (d) sCD40 levels and eGFR correlation, (e) association between sCD40 levels and KDIGO stage, and (f) sCD40 levels and CKD (SLE patients with an eGFR < 50ml/min/1.73m2). The qualitative gene expression analysis was obtained through to Pfaffl's method. Mann‐Whitney U test, Kruskal‐Wallis test, Dunn's post hoc test, and Spearman rank correlation coefficient were used, Fc was obtained through the 2 ‐ΔΔCq method. Data are shown in median and IQR. CS: Control Subjects, CKD: Chronic Kidney Disease, eGFR: estimated Glomerular Filtration Rate, KDIGO: Kidney Disease Improving Global Outcomes, Fc: Fold change, IQR: Interquartile range, SLE: Systemic Lupus Erythematosus

Journal: Molecular Genetics & Genomic Medicine

Article Title: Association of soluble CD40 levels with ‐1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus

doi: 10.1002/mgg3.1014

Figure Lengend Snippet: CD40 gene expression and sCD40 levels according to SLE activity. (a) CD40 gene expression according to disease activity (b) sCD40 levels according to disease activity, (c) sCD40 levels and SLICC damage index correlation, (d) sCD40 levels and eGFR correlation, (e) association between sCD40 levels and KDIGO stage, and (f) sCD40 levels and CKD (SLE patients with an eGFR < 50ml/min/1.73m2). The qualitative gene expression analysis was obtained through to Pfaffl's method. Mann‐Whitney U test, Kruskal‐Wallis test, Dunn's post hoc test, and Spearman rank correlation coefficient were used, Fc was obtained through the 2 ‐ΔΔCq method. Data are shown in median and IQR. CS: Control Subjects, CKD: Chronic Kidney Disease, eGFR: estimated Glomerular Filtration Rate, KDIGO: Kidney Disease Improving Global Outcomes, Fc: Fold change, IQR: Interquartile range, SLE: Systemic Lupus Erythematosus

Article Snippet: The sCD40 levels were determined using a commercial ELISA test (DCCD40 Quantikine ELISA kit [R&D Systems ® ]) according to manufacturer's conditions.

Techniques: Expressing, Activity Assay, MANN-WHITNEY, Filtration